Mumbai 400072, India
+91-90045 60540
info@omnisciencecapital.com

Tag: value investing

Science of Alpha from Safety

Are all Negatives already Discounted by the Market?

Are all Negatives already Discounted by the Market? If yes, where do the markets move from here? Disclaimer: Any mention of company names DOES NOT mean an endorsement or recommendation to buy, sell or hold any of these companies, sectors or the index or index-linked products. This is not investment advice, please see the detailed…
Read more

It is time for action

It is Time for Action

It is Time for Action When the valuations are favorable, the Scientific Investor starts investing Let us begin with the clarification that this is not—and cannot be—investment advice which depends on each individual’s specific circumstances, objectives and risk profile. The question on many people’s minds today is should they invest or exit? We are giving…
Read more

How to identify the right stock and avoid losing money

Synopsis Here are some ways to identify the right stock and avoid the wrong ones. The biggest fear while investing in equities for every investor — big or small — is about losing money. Here, we will look at some of the ways people lose money in equities, and how to avoid them. In order…
Read more

Your three-step guide to not getting singed in a market that is currently on steroids

Synopsis Equities are volatile and risky. The ups and downs might be difficult for many investors to tolerate. But, if one educates oneself to learn the basics of equity investing and risk tolerance, this journey can be quite rewarding. Pay yourself first. This is the advice on saving a part of your monthly salary or…
Read more

BBBY Life From Home Work From Home

Bed, Bath & Beyond: A Life-From-Home Special Situation

Summary We analyze BBBY using OmniScience Capital’s Scientific Investing Framework. Life-From-Home or “home nesting” was catalyzed as a consequence of Covid-19 Work-From-Home. BBBY provides direct exposure to this, now secular, trend. BBBY is turning around to be a company with persistent competitive advantages, targeting a large TAM and available at a significant discount to intrinsic…
Read more

Stock Market Scientific Investing

Scientific investing protects, creates wealth beyond the bull market rush

The Stock Market-A giant machine to transfer the wealth of the cult of momentum to Scientific Investors. Choose to be on the right side of wealth creation. As the cult of momentum is reinforced by the bull market, the participants go crazy…But a minority of market participants understand the scientific investing way based on the…
Read more

DAILY VOICE: Earnings downgrades could happen in COVID affected sectors in upcoming quarter: Dr. Vikas Gupta of OmniScience Capital

Dr. Vikas V Gupta, CEO & Chief Investment Strategist, OmniScience Capital, believes that given the lockdowns, it is likely that earning downgrades could happen in sectors that deal with perishable goods and services. In an interview with Moneycontrol’s Kshitij Anand, Gupta said that investors should look for companies benefiting from life from home theme that includes WFH,…
Read more

Demystifying equities-Understanding the potential risks and returns

Synopsis Let us decide to increase our risk tolerance. Easier said than done. So how do we go about it? The mantra we will use is “Knowledge Overcomes Fear”. The more you know and understand about equities the more risk tolerant you are likely to become over time. Dear HENRYs & other NRIs, a rational…
Read more

Sensex, Nifty still far from pre-COVID levels, but over 180 stocks have achieved the goal

Published in Moneycontrol Indian benchmark indices are at a 6-month high but are still 5 percent away from pre-COVID levels. The first case for COVID in India was registered on January 30. Sensex closed at 40,913 and Nifty50 ended at 12,035 that day. Read more about OmniScience Capital’s views on opportunities in Indian mid and smallcaps…
Read more

Is Mr. Market chasing the SuperNormal Portfolio?

India OmniView July 2020 Market has just begun unlocking the value in the ‘Unique’ SuperNormal portfolio Recently, Scientific Investing strategies have had a high absolute performance and outperformance relative to the benchmarks, as well as to other PMS or mutual fund managers. The performance has been broad-based across market caps and countries (US and India).…
Read more